In tumor tissues, CD109 was immunohistochemically detected in SCCs [11–18] as well as urothelial carcinomas [19], malignant melanomas [20], basal-like breast carcinomas [21], myxofibrosarcoma [22], epithelial sarcomas [23] and glioma [24]. Here, CD109 is linked to glioma.